Agilent Sulfa Drugs Application Note

This document provides a method for separating sulfonamide drugs using a Polaris 5µ C18-A, 150 x 4.6mm Part Nr.: A2000150X046 column


Agilent Sulfa Drugs Application Note - cover page
Brand
Agilent
Category
Other
Document type
Application Note
Language
English
Pages
1
File format
PDF
File size
40 KB
Published
12 June, 2012
Updated
30 September, 2023
MD5 checksum
C2B9CDE2EBCC8F83A0518084E7600FD2

About this manual

This document serves as an application note for the analysis of sulfa drugs using liquid chromatography. It specifies the use of the Agilent Polaris 5u C18-A column with dimensions of 150 x 4.6mm.

The note provides specific experimental parameters including the eluent composition (20mM K2HPO4, pH 9.0 mixed with MeCN 92:8), flow rate of 21.5 ml/min, and UV detection at 270nm. It identifies four specific peaks: sulfanilic acid, sulfamerazine, sulfisoxazole, and sulfapyridine.

What's inside

  • Sulfa drugs
  • LC Column
  • Peak Identification
  • Eluent
  • Detection

Specifications

ColumnPolaris 5u C18-A, 150 x 4.6mm
Eluent20MM K2HPO4, pH 9.0: MeCN 92:8
Flow21.5 ml/min
DetectionUV @ 270nm

Frequently asked questions

Which sulfa drugs are identified in this application note?

The note identifies sulfanilic acid, sulfamerazine, sulfisoxazole, and sulfapyridine.

What is the stated column specification for this application?

The document specifies using a Polaris 5u C18-A column with dimensions of 150 x 4.6mm.

What are the required eluent conditions for this analysis?

The procedure requires an eluent of 20MM K2HPO4 at pH 9.0 mixed with MeCN in a ratio of 92:8.

What is the specified flow rate and detection wavelength?

The analysis uses a flow of 21.5 ml/min with UV detection set to 270nm.

Download PDF (40 KB)

More Agilent Manuals


View all Agilent manuals →